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Endoscopic resection has been accepted as a curative modality for early gastric cancer (EGC). Since conventional endoscopic mucosal 
resection (EMR) has been introduced, many improvements in endoscopic accessories and techniques have been achieved. Recently, 
endoscopic submucosal dissection (ESD) using various electrosurgical knives has been performed for complete resection of EGC and en-
ables complete resection of EGC, which is difficult to completely resect in the era of conventional EMR. Currently, ESD is accepted as the 
standard method for endoscopic resection of EGC in indicated cases. In this review, the history of endoscopic treatment for EGC, overall 
ESD procedures, and indications and clinical results of endoscopic treatment will be presented. 
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Introduction
Endoscopic resection has been accepted as a curative modality 
for early gastric cancer (EGC) in indication of complete resection 
without the risk of metastasis. Since conventional endoscopic 
mucosal resection (EMR) has been introduced from 1984, many 
improvements of endoscopic accessories and techniques have 
been achieved.(1) Recently, endoscopic submucosal dissection 
(ESD) using various electrosurgical knives has been performed 
for complete resection of EGC, and enables complete resection of 
EGC which had many technical difficulties in complete resection 
in the era of conventional EMR. 
As the proportion of EGC has been increasing by early 
detection with national cancer screening program in Korea (biannual 
upper endoscopy or barium study for all population over age of 
40), endoscopic treatment for EGC has been expanded with the 
progress of endoscopic technique and accessories. In this review, 
endoscopic resection for EGC would be presented as the history, 
indication, risk of lymph node metastasis and clinical results. 
History of Endoscopic Resection for EGC
Since endoscopic resection with electrosurgical snare has been 
introduced for colorectal polyp in 1973, endoscopic resection has 
been performed for polypoid-type EGC as curative intent. In 1984, 
strip biopsy method has been developed for resection of flat-type 
EGC. In this method, the flat lesion is changed to polypoid lesion 
by submucosal injection of mixture of normal saline with diluted 
epinephrine, and resected by grasper forcep and electrosurgical 
snare through 2-channel endoscope. Although this method had 
advantages of easy technique, short procedure time and less 
complication, complete resection rate was around 50~70%, which 
was lower than expected for large-sized or depressed-type EGC.(2)
In 1988, EMR-precutting method has been developed, in 
which after hypertonic saline with diluted epinephrine is injected 
to submucosal layer around the lesion, circumferential incision 
around the lesion with needle knife and final resection of the lesion 
is performed with electrosurgical snare. This method has enabled 
complete en-bloc resection rather than conventional EMR, but Endoscopic Treatment for Early Gastric Cancer
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risk of perforation was higher during the circumferential incision, 
which necessitated higher expertise. Moreover, en-bloc complete 
resection was still difficult for large-sized or depressed-type EGC. 
In 1992, EMR by the cap-fitted method (EMR-C) has been 
developed, in which en-bloc resection was performed with 
electrosurgical snare after suction of the lesion by cap-fitted 
endoscope.(3) Although this method was easier and safer than 
conventional EMR for en-bloc resection of small-sized EGC, en-
bloc complete resection was still impossible for larger-sized EGC 
than diameter of the cap.(4)
To overcome the disadvantages of previous methods, ESD has 
been developed in late 1990’s. In ESD, circumferential incision and 
direct dissection of submucosal layer of EGC has been possible 
with various knives, which has enabled en-bloc complete resection 
even in large-sized or depressed-type EGC. Various knives have 
been introduced for safe and complete ESD for EGC, and have 
different advantages/disadvantages according to the lesion. In 
present, insulation-tipped (IT), triangle-tipped (TT), flex, hook, 
fork, flush and splash knives are available for ESD.
Procedure of ESD
ESD is usually performed under sedation with intravenous 
midazolam or propofol. With a standard single-channel endoscope, 
thorough examination is mandatory for the evaluation of whole 
stomach including the target lesion. After the chromo-endoscopic 
observation with indigo carmine, marking dots 5 mm outside the 
tumor margin are made using a conventional needle knife with 
a forced 20 W coagulation current (VIO 300D; Erbe, Tübingen, 
Germany) or argon plasma coagulation. Then a mixture of normal 
saline and indigo carmine with diluted epinephrine (1 : 100,000) 
is injected into the submucosal layer along with the marking dots 
to make the submucosal cushion beneath the lesion. After a small 
initial incision is made with the needle knife, a circumferential 
mucosal incision is made around the marking spots, and the 
submucosal layer is dissected using various knives in 80 W endocut 
mode. Hemostasis is usually performed for bleeding spots or visible 
vessels with a coagrasper or argon plasma coagulation. After ESD, 
the patients is administered proton pump inhibitors intravenously at 
the day of procedure and then orally for four weeks for the healing 
of iatrogenic ulcer, pain control and prevention of perforation or 
post-procedural bleeding.
Selection of Knife
Knife is divided into blade- and tip-type according to resection 
Fig. 1. ESD for EGC from marking, submucosal injection, circumferential incision to submucosal dissection. ESD = endoscopic submucosal dissec-
tion; EGC = early gastric cancer.Kim SG
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site. Blade-type; needle, IT and TT knife, Tip-type; flex, hook, 
fork, flush and splash knife. 
Needle knife is usually used in sphincterotomy during endos-
copic retrograde cholangiopancreatography, and generates both 
cutting and coagulation current by electrosurgical unit. It has been 
used in submucosal dissection for the first time as a simple type.
At first, needle knife is used in marking around the lesion with 
coagulation current by adjustment of needle length up to 6 mm. 
Long needle has the risk of bleeding or perforation by attachment 
of needle to coagulated mucosa. Circumferential incision should be 
performed with cutting current by step by step for the prevention 
of perforation. In submucosal dissection, caution should be kept 
whether dissection is accurately made in submucosal layer. 
Needle knife usually necessitates transparent cap at the tip of 
endoscope for prevention of perforation. Although needle knife 
has a high speed in resection, longer time can be needed in a 
beginner for the risk of perforation. Nowadays, needle knife is used 
for making the hole at the beginning rather than circumferential 
incision or submucosal dissection. 
IT knife has an insulated tip of 2.2 mm in diameter for the 
prevention of perforation.(5) Since Hosokawa from Japan has 
introduced in 1996, IT knife has been used in ESD. It can be used 
in circumferential incision and submucosal dissection, even in 
hemostasis of minor bleeding with coagulation current. 
After making the incision hole with needle knife, circumferen-
tial incision around the lesion is made with IT knife. Insulated tip 
has an advantage of prevention of perforation even in dead angle. 
Pull-method with angle of 45 degree from distant part is favorable 
in incision. In submucosal dissection, full utilization of blade with 
insulated tip has advantages of shorter procedure time with fast 
dissection and prevention of perforation even in dead angle. Push-
method from nearest part or pull-method from distant part is 
favorable in submucosal dissection.
The lesion in perpendicular plane such as fundus or greater 
curvature of upper body is limited in resection with IT knife, and 
perforation can occur even with insulated tip by whole-blade 
resection. Although easy procedure and short procedure time 
can be advantages to experts, unexpected perforation may be a 
disadvantage to beginners.(6)
TT knife has a triangle diathermic disc at the tip of 4.5 
mm in length, and can be used in marking around the lesion, 
Fig. 2. Various knives used in ESD. (A) IT knife, (B) TT knife, (C) Flex knife, (D) Hook knife, (E) Fork knife, (F) Flush knife, (G) Splash knife. ESD 
= endoscopic submucosal dissection; IT = insulation-tipped; TT = triangle-tipped.
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circumferential incision and submucosal dissection, even in 
hemostasis of minor bleeding with coagulation current. 
After hole-making with TT knife alone, circumferential incision 
around the lesion is performed with pull-method from distant 
part. In submucosal dissection, pull-method with diathermic disc is 
performed from distant part by step by step. Apart from IT knife, 
dissection with diathermic disc alone needs longer procedure time. 
The risk of perforation in dead angle can be reduced by fitting 
transparent cap which enables direct vision of dissection. 
Flex knife has a tip of soft semicircular snare, and can be 
used in marking around the lesion, circumferential incision and 
submucosal dissection, even in hemostasis of minor bleeding with 
coagulation current.(7) Soft semicircular snare is contained in soft 
plastic case, and can be adjusted in length. 
After marking, circumferential incision around the lesion is 
performed with 1 mm in length from distant part. Push-method is 
used with 1~1.5 mm in length from proximal part in submucosal 
dissection. The risk of perforation is minimized because of bending 
of knife with soft nature even in jerky movement. Submucosal 
dissection by step by step has longer procedure time, and dead 
angle necessitates fitting transparent cap to prevent perforation. But 
accurate dissection can be performed by direct vision of dissected 
submucosa. Also, flex knife with soft nature enables dissection in 
every direction, even in perpendicular plane. Fixed maintenance of 
length of knife is indispensible to prevent unexpected perforation 
in jerky movement. 
Hook knife has a hooked tip with 4.5 mm long and 1.3 mm 
in transverse, and can be used in marking around the lesion, 
circumferential incision and submucosal dissection, even in 
hemostasis of minor bleeding with coagulation current.(8) The tip 
is rotatable in 360 degree to dissect in every direction. Methods 
of marking, submucosal injection, circumferential incision and 
submucosal dissection are same as TT knife.
Fork knife developed in Korea has an advantage of marking, 
incision, dissection, hemostasis, injection and irrigation by one 
knife without changing accessories.(9) Fork knife is composed of 
needle used in marking and incision and fork used in injection and 
dissection, which can be handled separately. Methods of marking, 
submucosal injection, circumferential incision and submucosal 
dissection are same as flush knife. Major advantage of fork knife 
is time-saving because of total procedure in one knife without 
changing accessories. But, needle knife has a risk of perforation 
during incision, and difficulties in procedure in case of inaccessible 
location. Submucosal dissection with fork by step by step has longer 
procedure time, and dead angle necessitates fitting transparent cap 
to prevent perforation. But accurate dissection can be performed by 
direct vision of dissected submucosa. 
Flush knife has an advantage of marking, incision, dissection, 
hemostasis, injection and irrigation by one needle-type without 
changing accessories.(10) Methods of marking, submucosal 
injection, circumferential incision and submucosal dissection are 
same as fork knife. 
Splash knife has an advantage of marking, incision, dissection, 
hemostasis, injection and irrigation by one needle-type without 
changing accessories.(11) Knife is 2.5 mm long and controllable. 
Methods of marking, submucosal injection, circumferential incision 
and submucosal dissection are same as flush knife. 
Selection of knife is dependent on the lesion by each 
characteristic. Although most procedure is performed with one 
knife, various knives can be utilized for accurate and safe procedure 
by case by case. Decision factors of knife are location, morphology, 
size of the lesion and type of procedure. But most of all, familiarity 
to operator is most important. That is, most important factor of 
selection of knife is easiness and familiarity to operator.
 In cases of stomach, the lesion of greater curvature of high 
body, fundus and angle is difficult to manage. The lesion of greater 
curvature of high body and fundus is perpendicular with knife, and 
is difficult to manage with IT and TT knife. On the other hand, 
the lesion of angle can be difficult to approach and manage with 
flex, fork, flush and splash knife which should contact the lesion to 
dissect because of excessive air inflation during procedure. IT knife 
has an advantage in management of inaccessible lesion. 
Submucosal dissection can be difficult for excessive fibrosis in 
the lesion with submucosal fibrosis or underlying scar formation. 
IT knife has an advantage of wide dissection plane and shorter 
procedure time in experts. To shorten the procedure time for large 
lesion, IT knife has an advantage of wide dissection plane, and 
fork, flush or splash knife has an advantage of total procedure with 
one knife to shorten the procedure time. 
Conventional Indication of Endoscopic 
Resection for EGC
As the technical progress has achieved from conventional EMR 
to ESD, most of limiting factors in complete en-bloc resection have 
been overcome irrespective of size, shape or location of the tumor, 
which has resulted in the expansion of the indication of endoscopic 
resection for EGC. Moreover, ESD has been substituted for surgical Kim SG
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resection with increased portion of old age and co-morbidity and 
importance of postoperative quality of life.
Prior to expansion of indication of endoscopic resection for 
EGC, the prerequisite is to maintain the quality of life without the 
sacrifice of survival, which means that the expanded indication 
should only include EGC without lymph node or distant metastasis, 
enable complete en-bloc resection without serious complication, 
and ensure long-term survival not inferior to surgical resection. 
Therefore, the expansion of indication of endoscopic resection for 
EGC has a pitfall in the possibility of sacrifice of survival in the 
setting of insufficient results of long-term survival after endoscopic 
resection for EGC.
Conventional indication of endoscopic resection for EGC is 
as follows, 1) differentiated adenocarcinoma confined to mucosa, 
2) elevated type ≤2 cm, 3) depressed type without ulcer ≤1 
cm. In this indication, the tumor rarely metastasizes to regional 
lymph node or distant organ and can be resected endoscopically 
with negligible risk of recurrence.(12) Beyond the conventional 
indication, the tumor in most cases could not be resected 
completely by conventional EMR with low cure rate in spite of 
the possibility of candidates of endoscopic resection. Therefore, 
indication of endoscopic resection was confined to small-sized, 
superficial tumor which could be resected with en-bloc fashion in 
the era of conventional EMR. 
In the era of ESD, most limiting factors have been overcome 
in complete resection, and the indication of ESD is decided by 
the risk factors of lymph node or distant metastasis.(13) Although 
the risk factors of lymph node or distant metastasis are generally 
accepted as 1) tumor size, 2) differentiation of tumor, 3) invasion 
depth of tumor, and 4) angiolymphatic invasion of tumor, definite 
indications of endoscopic resection for EGC are variable according 
to the studies because of 1) different indication according to studies, 
2) retrospective manner, 3) small sample size, and 4) short-term 
follow-up period. 
Risk Factors of Lymph Node 
Metastasis in EGC
Although the risk of lymph node metastasis in EGC increases 
with tumor size, depth of tumor invasion and undifferentiated 
histology, definite indication of endoscopic resection for EGC is 
variable according to the studies, and the standard indication is not 
established.(14) 
In a retrospective study with surgically-resected cases with 
EGC, the expanded indication of endoscopic resection for EGC 
was proposed with no evidence of lymph node metastasis in; 1) 
differentiated mucosal cancer without ulcer irrespective of size, 2) 
differentiated mucosal cancer with ulcer ≤3 cm, 3) undifferentiated 
mucosal cancer ≤2 cm, 4) differentiated submucosal cancer ≤500 
μm depth of invasion (sm1) ≤3 cm in size without angiolymphatic 
invasion.(15,16)
On the other hand, lymph node metastasis was found in 4.5% 
of mucosal cancer and 22.8% of submucosal cancer in another 
retrospective study with 2,173 surgically-resected cases of EGC.
(17) Of those, lymph node metastasis was found in some of 
differentiated mucosal cancer without ulcer and 2 cm differentiated 
mucosal cancer with ulcer, which explains that the risk of lymph 
node metastasis is not negligible even in the expanded indication of 
endoscopic resection for EGC.
Although undifferentiated histology is not considered to be the 
indication of endoscopic resection with higher risk of lymph node 
metastasis rather than differentiated histology, some portion may 
be the indication of endoscopic resection with negligible risk of 
lymph node metastasis. In a retrospective study with 591 surgically-
resected cases of undifferentiated EGC, there was no lymph node 
metastasis in 119 cases with tumor size less than 2.5 cm, confined 
to mucosa or sm1, and without angiolymphatic invasion, which 
might be the expanded indication of endoscopic resection.(18)
In the expanded indication of endoscopic resection for EGC, 
the pre-evaluation of regional lymph node and distant metastasis 
is very important with the increment of risk of metastasis.(19) As 
the risk factors of lymph node metastasis such as accurate tumor 
size, differentiation, depth of tumor invasion and angiolymphatic 
invasion cannot be known prior to endoscopic or surgical resection, 
the risk of lymph node metastasis is restricted to assumption 
in pretreatment staging. Although endoscopic ultrasonography, 
computerized tomography, positron emission tomography have 
been used in cancer staging, diagnostic accuracy for lymph node 
or distant metastasis varies in 50~80%. To expand the indication 
of endoscopic resection for EGC, new diagnostic modality is 
mandatory for the evaluation of lymph node metastasis prior to 
definitive treatment.
Most of all, long-term survival after endoscopic resection 
should be proven to be not inferior to that after surgical resection to 
expand the indication of endoscopic resection for EGC. Although 
conventional EMR for conventional indication have shown long-
term survival not inferior to surgical resection in completely-
resected cases, long-term survival after ESD has not been Endoscopic Treatment for Early Gastric Cancer
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established without sufficient data. Long-term prospective study is 
warranted for long-term survival after ESD for EGC. 
Standardization of Risk Factors of Lymph 
Node Metastasis in EGC
Risk factors of lymph node metastasis in EGC are known 
to be tumor size, depth of tumor invasion, differentiation and 
angiolymphatic invasion, which have variable criteria according 
to the studies.(20) In tumor size, discrepancy may exist between 
surgically-resected and endoscopically-resected specimen. In 
surgical resection, the tumor size is measured after fixation with 
formalin, which may be reduced by shrinkage. On the other hand, 
the specimen is creased and fixed with pin in endoscopic resection, 
which may be exaggerated in size. Therefore, the study with 
endoscopically-resected cases may show the result of expanded 
indication in tumor size rather than the study with surgically-
resected cases. 
Depth of tumor invasion can be confused in endoscopically-
resected cases. On the contrary to surgically-resected specimen, 
endoscopically-resected specimen does not include all layers 
of stomach but mucosa and partial submucosa. In the cases of 
submucosal invasion of tumor, accurate depth of tumor invasion 
cannot be verified in endoscopically-resected specimen because 
of lack of muscularis propria which can be the standard of 
interpretation. Although submucosal layer is divided by 3 with 500 
μm, depth of tumor invasion can be much influenced by tissue 
preparation after endoscopic resection. 
Intra- or inter-observer variation among pathologists can exist 
in the evaluation of differentiation of tumor. High grade dysplasia 
vs. intraepithelial carcinoma is the main diagnostic problem 
among the pathologists. In favor of diagnosis of cancer rather than 
dysplasia, the indication of endoscopic resection may be expanded 
without the risk of lymph node metastasis. To standardize the risk 
of lymph node metastasis in EGC, the definition of size, depth of 
invasion and differentiation of tumor should be also standardized. 
Clinical Results of Endoscopic 
Resection for EGC
Conventional EMR has shown unsatisfied results in terms of 
en-bloc complete resection, which lay from 53~74% according 
to size, shape or location of EGC.(21) On the other hand, there 
is no limiting factor in ESD in terms of size, shape or location of 
EGC. ESD enables en-bloc complete resection of larger-sized, 
depressed-type with submucosal fibrosis or difficult-located EGC. 
But ESD has disadvantages of longer procedure time and higher 
complication rate in terms of bleeding or perforation rather than 
conventional EMR, and necessitates a longer learning curve and 
expertise.(22) Therefore, conventional EMR can be still applied for 
small-sized, polypoid-type EGC rather than ESD regarding to risk 
and benefit.
Success rate of conventional EMR was influenced by tumor 
size, shape and location, and lowered in larger size than 2 cm, 
depressed type and location of body lesser curvature or posterior 
wall.(23) On the contrary to conventional EMR, ESD has much 
improved the complete en-bloc resection rate. Although complete 
resection was achieved in 77.6% in a study with conventional 
EMR, another study with ESD in 1,000 cases has revealed en-
bloc resection rate of 95.3% and complete resection rate of 87.7%.
(24) From 2005 to 2010, a total of 690 cases with EGC were treated 
by ESD in Seoul National University Hospital. En-bloc resection 
was achieved in all cases, and complete resection rate was 94.2% in 
cases with expanded indication. 
ESD has a higher risk of complication and longer procedure 
time than conventional EMR because of larger and deeper 
dissection. Bleeding and perforation are the most common 
complication of ESD, which can be reduced by expertise. In a 
study, major bleeding rate was 0.6% and perforation rate was 1.2% 
with mean procedure time of 47.8 minutes.(24) Most of bleeding 
and perforation can be managed by endoscopic hemostasis and 
clipping without surgical management.
After confirmation of complete resection of EGC at pathological 
mapping, periodic regular follow-up is performed to detect 
recurrence. 5-year recurrence free survival is estimated to 99% and 
overall survival is estimated to 95%, which is comparable to surgical 
resection. Among 620 cases complete-treated by endoscopic 
resection in Seoul National University Hospital, 1 case of mortality 
by cardiovascular event was reported, and disease-free survival 
was 100% during follow-up. Considering the quality of life after 
treatment, ESD is a safe and effective treatment for EGC without 
sacrifice of survival compared to surgical resection.
Recurrence after Endoscopic 
Resection for EGC
Recurrence can be defined as the relapse of previous lesion, 
which includes local recurrence, synchronous or metachronous Kim SG
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lesion, and distant metastasis. However, recurrence of narrow 
definition is remnant lesions at the site of treatment or metastatic 
lesions related with previous lesions treated.
Local recurrence is defined as remnant or relapsed cancer at 
same site after endoscopic resection during follow-up. ESD which 
enables en-bloc complete resection of larger tumor has reduced 
the rate of local recurrence of tumor compared with conventional 
EMR. Although local recurrence usually develops in a short-term 
period less than 6 months after initial resection, minute remnant 
cancer can grow up to gross mass after 1 year.
Local recurrence originates from remnant tumor in incomple-
tely-resected site. In case of positive lateral resection margin at 
post-resection pathological mapping, remnant tumor around 
resection margin can grow with healing of iatrogenic ulcer after 
resection. On the contrary, remnant tumor can infiltrate submucosal 
or deeper layer in case of positive vertical resection margin in post-
resection pathological mapping. 
Local recurrence can develop even after complete resection of 
tumor. Overlooked skipped tumor is not rare around main lesion in 
EGC, which can lead to local recurrence when the skipped lesion is 
not included in the resected specimen. To prevent overlooking the 
skipped lesion, sufficient resection margin should be guaranteed in 
case of ill-defined tumor margin. 
If the post-resection pathological mapping has revealed the 
positive lateral resection margin, remnant tumor can exist around 
resection margin. All cases with positive lateral resection margin, 
however, have not remnant tumor. Mucosal cancers with positive 
lateral resection margin have been reported to have remnant tumor 
only in 5.8%. Because cautery effect can ablate the remnant tumor 
around the circumferential incision during ESD, local recurrence 
can be prevented even in incomplete resection in terms of lateral 
margin. Therefore, frequent short-term endoscopic follow-up 
can be applied for detection of local recurrence in case of minute 
involvement of tumor in lateral resection margin. 
When the local recurrence has developed in case of positive 
lateral resection margin, definitive treatment should be made for 
remnant cancer. If the remnant cancer is still confined to mucosa 
and the result of previous pathologic mapping has shown the 
negligible risk of lymph node metastasis in criteria of tumor size, 
differentiation and depth of tumor invasion, additional endoscopic 
resection can be applied to remnant cancer. However, secondary 
endoscopic resection could be more difficult in technique because 
of submucosal fibrosis after healing of iatrogenic ulcer. Sufficient 
resection margin should be ensured to prevent repetitive recurrence 
after additional endoscopic resection. Therefore, endoscopic 
ablation treatment with argon plasma coagulation (APC) can be 
applied at the site of repeated ESD as additional therapy. If the 
result of previous pathological mapping has revealed beyond 
the indication of endoscopic resection such as larger tumor 
size, positive angiolymphatic tumor invasion or undifferentiated 
histology, additional gastrectomy with conventional lymph node 
dissection should be made for the removal of risk of lymph node 
metastasis as well as remnant cancer. 
Endoscopic ablation treatment can be applied to remnant tumor 
in endoscopically-unresectable and surgically-inoperable cases 
such as old age or significant co-morbidity. APC is useful for the 
ablation of superficial tumor and can be repeated with interval until 
complete resolution of remnant tumor. 
When the local recurrence has developed in case of positive 
vertical resection margin, tumor can infiltrate submucosal or deeper 
layer because the method of ESD removes most of mucosal and 
submucosal layer. Therefore, additional gastrectomy and lymph 
node dissection should be made in case of positive vertical resection 
margin. 
Synchronous lesion is defined as multiple tumors at diagnosis or 
newly-detected tumor within one year after initial resection. One-
year interval is arbitrary because exact time of tumor initiation 
cannot be resolved. A tumor detected within one year after initial 
resection might exist at initial diagnosis because conventional 
endoscopy could not detect minute tumor less than 5 mm in size 
at initial diagnosis. Especially, tumor more than 5 mm in size 
within one year after initial resection could be exist even at initial 
diagnosis in viewpoint of doubling time of tumor. Metachronous 
tumor is defined as newly-developed tumor after one year of 
endoscopic resection. During follow-up after endoscopic resection, 
metachronous tumor develops at rate of 1~3% per year. 
The management of synchronous or metachronous tumor 
depends on status of respective tumor. If the tumor is indicated in 
endoscopic resection, ESD can be applied for complete resection. 
On the contrary, surgical resection should be applied in case 
beyond indication of endoscopic resection. 
Conclusions
ESD has been a curative treatment modality of EGC in selective 
indications. The complete resection rate, long-term disease-free 
results and survival has been comparable to surgical treatment 
with the progress of endoscopic technique and accessories. After Endoscopic Treatment for Early Gastric Cancer
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complete resection, regular follow-up examination is mandatory 
for the detection of metachronous tumor development. 
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